Licensing Agreement
4 stories covering licensing agreement — fund closes, LP allocations, regulatory filings, deal flow, and fundraising signals from PipelineRoad's editorial team.
NorthStrive Biosciences Amends Licensing Agreement with MOA Life Plus
PMGC Holdings subsidiary NorthStrive Biosciences updates milestones for EL-32 and EL-22 in licensing deal with Korean biotech firm MOA Life Plus, as announced on March 27, 2026.
Hudson Technologies Signs Refrigerant Licensing Agreement with Solstice
Hudson Technologies has agreed to reclaim and resell specific HFO refrigerants under a licensing deal with Solstice Advanced Materials, as announced on March 27, 2026.
Yatiri Bio Enters Exclusive Option Agreement for Denfivontinib with Oscotec
Yatiri Bio announces an exclusive global option to license denfivontinib from Oscotec for AML treatment, using its AI-driven platform.
VVMF Secures Licensing Agreement with OXB for Viral Vector Platforms
Australia's Viral Vector Manufacturing Facility enters licensing deal with OXB for access to advanced viral vector technologies, announced on March 18, 2026.